Directory → Hormones and their antagonists → Adrenal → Glukokortikoida → Benakort
This page is translated automatically with a help of Google Translate
BenakortSee also BudesonideRoman nameBenacortThe composition and the form ofone dose powder inhalations budesonida contains 200 µ g, as well as sodium benzoate 9.8 mg; in inhalers ziklohaler 100 or 200 doses, in a carton 1 pc.CharacteristicsMelkochristalliceski powder white, or nearly white.Of drugsПротивовоспалительно е. Oppressing synthesis lakotrienov and NG products Cytokines, suppressing the inflammatory process in the walls of the bronchi, consequential T-limfozitami.FarmakodinamikaImpact giperreaguosti bronchi, improves lung function and mukotiliarnyi Cl. Provides local view противовоспалительно е Effects. And protivogribkova (fungicidal) activity and helpful to patients (sodium benzoate).IndicationsBronchial asthma (prevention and treatment), including : against fungal disease mucous membranes of the oral cavity and bronchi.Pregnancy and lactationPerhaps only after consultation with the doctor.ContraindicationsГиперчувствительност ь.Side-EffectsLocal : rarely ohriplosti vote, and sometimes cough (through inappropriate technology inhalation).Patient interactionAdrenomimetiki (salbutamol, etc.) increased effect.Dosing and AdministrationInhalation, using a portable ingalatora ziklohaler. Under the dose of 200 micrograms, daily-prepared individually in the light of the gravity of the disease and supporting dose glucocorticoids tablets; Frequency reception from 2 to 4 inhalations per day. Initial daily intake - time 2-8 doses per day (400-1600 µ g), maintenance treatment-1-4 doses per day (800 g) in the period increased from 4 to 8 doses per day. After reaching effects should not be drastically cut treatment (dose to be reduced progressively). Be wary appoint patients with pulmonary tuberculosis disease in chicken. It eliminates asthma status. While receiving corticosteroid inwards on treatment Benakortom be in a stable phase of the disease combining with inhalation oral therapy for 14-20 days, then gradually reduce the dose for admission into the complete elimination (if possible).Storage conditionspor.d / ingal.doz. : List B. In dry the dark place at a temperature of no higher than 25 ° CShelf lifepor.d / ingal.doz. : 3 and |
All products of this group |

